Landscapes / Targets
tumor neoantigens
5 drugs act on tumor neoantigens, in 5 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs5
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | Aug 2027Phase 1/2 trial completes | |||
| Next date | Aug 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Solid Tumors, Advanced Cancer and 3 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 30 Dec 2027Phase 1/2 trial completes | |||
| Next date | 30 Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Squamous Cell Carcinoma of Head and Neck | ||||
| Open drug page | |||||
— |
Phase 1/2 | Dec 2030Phase 1/2 trial completes | |||
| Next date | Dec 2030 · Phase 1/2 trial completes | ||||
| Also tested for | Colorectal Cancer | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Solid Tumor, Adult | ||||
| Open drug page | |||||
— |
Akeso · Public 9926.HK |
Phase 1 | 23 Feb 2028Phase 1 trial completes | ||
| Next date | 23 Feb 2028 · Phase 1 trial completes | ||||
| Also tested for | Pancreas Cancer, Pancreas Cancer, Duct Cell Adenocarcinoma | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 5 of 5 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026